Skip to main content

Bax, Bcl-2, Fas and Fas-L antigen expression in human seminoma: Correlation with the apoptotic index

Buy Article:

$51.00 plus tax (Refund Policy)

Grobholz R., Zentgraf H., Köhrmann K.-U., Bleyl U. Bax, Bcl-2, Fas and Fas-L antigen expression in human seminoma: Correlation with the apoptotic index. APMIS 2002;110:724–32.

Apoptosis plays a crucial role in the regulation of spermatogenesis in male germ cells and is, at least in part, modulated by Bcl-2, Bax, and the Fas pathway. Seminomas have a favourable outcome and respond to radio-/chemotherapy with an increased rate of apoptosis. The expression of Bax, Bcl-2, Fas and Fas-ligand (Fas-L) in human seminoma was evaluated and correlated with the apoptotic index.

Twenty-nine classical seminomas were examined by immunohistochemistry and Western blotting using antibodies against Bax, Bcl-2, Fas and Fas-L. Apoptosis was detected by in-situ end-labeling of fragmented DNA and the apoptotic index (AI) was determined.

Expression of Fas was found in 26 (89.7%) of Fas-L in 24 seminomas (82.2%); none of the tumours expressed Bcl-2. No correlation between the AI and Fas, Fas-L or Bcl-2 expression was found. Bax was demonstrated in 20/29 tumours (69%). Bax-positive tumours showed an increased AI of 4.75±2.38% in contrast to 2.60±1.23% of the Bax-negative tumours (P=0.002). The number of Bax-positive tumour cells and apoptotic cells revealed a significant correlation using χ2-test (P=0.04) and linear regression (r=0.54, P=0.001).

Therefore, Bax seems to play a determinant role in the modulation of apoptosis in human seminoma that may be linked to a favourable outcome.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Bax; Bcl-2; Fas; Fas-L; Seminoma; apoptosis

Document Type: Research Article

Affiliations: 1: German Cancer Research Centre, Department of Applied Tumor Virology, Heidelberg, 2: Department of Urology, Ruprecht-Karls-University Heidelberg, University Hospital Mannheim, Mannheim, Germany

Publication date: 2002-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more